Unlock instant, AI-driven research and patent intelligence for your innovation.

Fusion protein of granulocyte colony-stimulating factor (g-csf) and its mutant (mg-csf) with the third domain of human serum albumin (3dhsa) and its application

A technology of colony stimulating factor and human serum albumin, which can be applied in the fields of extracellular fluid diseases, peptide/protein components, medical preparations with non-active ingredients, etc. immune response and other issues to ensure accuracy and reduce screening workload

Active Publication Date: 2015-11-25
CHINA PHARM UNIV
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Although albumin fusion technology has been successfully applied to prolong the half-life of various protein or peptide drug molecules, there are still some aspects that need to be improved
First of all, since the molecular weight of albumin is about 66.5KD, it will produce obvious steric hindrance when fusing other proteins or polypeptides, resulting in a significant reduction in the activity of the fusion protein
Secondly, when yeast secretes and expresses albumin and its fusion protein, it is prone to degradation, and the physical and chemical properties of the degraded fragment are very similar to those of the fusion protein, which increases the difficulty of subsequent separation and purification
Finally, albumin fusion protein is prone to aggregation during storage, and it is easy to induce immune response in clinical application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fusion protein of granulocyte colony-stimulating factor (g-csf) and its mutant (mg-csf) with the third domain of human serum albumin (3dhsa) and its application
  • Fusion protein of granulocyte colony-stimulating factor (g-csf) and its mutant (mg-csf) with the third domain of human serum albumin (3dhsa) and its application
  • Fusion protein of granulocyte colony-stimulating factor (g-csf) and its mutant (mg-csf) with the third domain of human serum albumin (3dhsa) and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 13D

[0045] Cloning of embodiment 13DHSA-G-CSF and 3DHSA-mG-CSF fusion gene

[0046] For the amplification of 3DHSA-G10 and 3DHSA-mG10, the primers used are as follows:

[0047] P1: 5'TCT CTCGAG AAGAGAGTGGAAGAGCCTCAGAATTTAAT3' (with XhoI restriction site at the 5' end, CTCGAG), primer SEQNO:8.

[0048] P2: 5'CCAGCGGGGTTAAGCCTAAGGCAGCTTGAC3', primer SEQ NO:9.

[0049] P3: 5'ATGTGGGTGCTAAGCCTAAGGCAGCTTGAC3', primer SEQ NO:10.

[0050] The PCR method is as follows: Add 2 μL of 10 μmol / L upstream and downstream primers to the 50 μL system (the primers used to amplify 3DHSA-G10 are P1 and P2, and the primers used to amplify 3DHSA-mG10 are P1 and P3), 2.5 μmol / L dNTP 4 μL, 10 × Premistarbuffer 5 μL, 5 U / μL Premistar DNA polymerase 0.5 μL, pPICzαA-HSA-G-CSF plasmid (SEQNO: 7) 1 μL, the insufficient part was made up with sterilized double distilled water, the reaction conditions were: 94 ° C pre-denaturation for 5 min, 94 °C Denaturation at °C for 1 min, annealing at 56°C for 1 min, e...

Embodiment 2

[0060] The screening of embodiment 2 recombinant strains

[0061] The pPICzαA-3DHSA-G-CSF and pPICzαA-3DHSA-mG-CSF plasmids were extracted, linearized by SalI single enzyme digestion, the effect of the enzyme digestion was detected by agarose gel electrophoresis, and the enzyme digestion products were recovered with an agarose gel recovery kit. 1.5kV electroporation to transform Pichia pastoris GS115 competent cells, let stand at 30°C for 2h, spread the transformants evenly on 4 MD plates containing 1mol / L sorbitol, culture them upside down at 30°C for 3 days, and transfer the transformed clones Correspondingly marked and transferred to two newly prepared MD plates at the same time, cultured upside down at 30°C for 3 days, put the UV-irradiated PVDF membrane on the colony of one of the MD plates lightly, and place the UV-irradiated membrane on the membrane at the same time. 2 sheets of filter paper, soak the surface of the filter paper with 3mL of anhydrous methanol, continue ...

Embodiment 33D

[0062] Example 3 Induced expression and identification of 3DHSA-G-CSF and 3DHSA-mG-CSF fusion proteins

[0063] Inoculate the single colonies of GS115 / pPICzαA-3DHSA-G-CSF and GS115 / pPICzαA-3DHSA-mG-CSF screened into 100ml BMGY (0.3g dipotassium hydrogen phosphate, 1.18g potassium dihydrogen phosphate, 1.34g amino-free culture Base, 1g yeast powder, 2g peptone, 20μg biotin, 1mL glycerol, pH 6.0) in a 500ml Erlenmeyer flask, cultured at 220r / min, 30°C for 24h, centrifuged at 2000r / min for 5min, and collected the bacteria. Use 100ml of BMMY (0.3g dipotassium hydrogen phosphate, 1.18g potassium dihydrogen phosphate, 1.34g amino-free medium, 1g yeast powder, 2g peptone, 20μg biotin, 1mL anhydrous methanol, pH6.0) to resuspend the bacteria For precipitation, 1 mL of anhydrous methanol was added every 12 hours, and the induction continued for five days. Centrifuge at 8000r / min for 10min, collect the supernatant, and perform SDS-PAGE detection. The expression of the fusion protein in...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of a long-acting fusion protein medicine, and in particular relates to a fusion protein of a granulocyte colony-stimulating factor (G-CSF) as well as a mutant of the granulocyte colony-stimulating factor (mG-CSF) and a human serum albumin 3rd domain (3DHSA). The amino acid sequence of the human serum albumin 3rd domain of the fusion protein is expressed as SEQ NO: 1, and the amino acid sequences of the granulocyte colony-stimulating factor and mutant thereof are expressed as SEQ NO: 2 and SEQ NO: 3. The invention successfully constructs two fusion proteins for the first time, overcomes the shortcoming of short in vivo half-life period of the granulocyte colony-stimulating factor and provides a novel fusion protein molecule integrating characteristics of the human serum albumin 3rd domain and the granulocyte colony-stimulating factor. The fusion protein disclosed by the invention, on the basis of maintaining G-CSF bioactivity, has in vivo half-life periods of 3.3hours and 4.4hours which are about 1.6 and 2 times as much as the half-life period of the G-CSF, thereby providing an innovative drug molecule having a potential application value.

Description

technical field [0001] The invention belongs to the technical field of long-acting fusion protein drugs, and in particular relates to the preparation of fusion proteins of granulocyte colony stimulating factor and its mutants and the third domain of human serum albumin. Background technique [0002] Human granulocyte colony-stimulating factor (G-CSF) is a glycoprotein regulatory factor with a molecular weight of about 20KD produced by monocytes, fibroblasts, and endothelial cells, and its isoelectric point is about 6.0. G-CSF acts on bone marrow neutrophil lineage hematopoietic precursor cells to promote their proliferation, differentiation, maturation and release. G-CSF in the mature human body has two isomers of 177 amino acids (a type) and 174 amino acids (b) type. The helical content of the b type molecule is very high, and the crystal configuration contains four α helices, which belong to the long chain helix Cytokine family. In view of the fact that the biological ac...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K19/00A61K38/19A61K47/48A61P7/00
Inventor 高向东赵述强张瑜姚文兵田浤刘超陈晓菲
Owner CHINA PHARM UNIV